Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Weinstock

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Blood|December 1, 2018
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomasRaphael Koch, Amanda L Christie, Jennifer L Crombie, et al.
Nature Biotechnology|September 7, 2016
High-throughput measurement of single-cell growth rates using serial microfluidic mass sensor arraysNathan Cermak, Selim Olcum, Francisco Feijó Delgado, et al.
Disaster Medicine and Public Health Preparedness|March 16, 2011
Allocation of scarce resources after a nuclear detonation: setting the contextAnn R Knebel, C Norman Coleman, Kenneth D Cliffer, et al.
Health Physics|January 1, 2015
Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterpriseC Norman Coleman, Julie M Sullivan, Judith L Bader, et al.
Blood|October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphomaCaron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Molecular Cancer Therapeutics|August 29, 2023
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1Adrian Schwarzer, Matheus Oliveira, Marc-Jens Kleppa, et al.
Blood|October 7, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemiaMarlise R Luskin, Mark A Murakami, Julia Keating, et al.
Leukemia|July 31, 2025
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphomaTayla B Heavican-Foral, Felix Korell, Irene Scarfò, et al.
Cell|March 20, 2018
B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell MalignanciesGang Xiao, Lai N Chan, Lars Klemm, et al.
The Journal of Clinical Investigation|August 23, 2019
DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistanceKatsuhiro Togami, Timothy Pastika, Jason Stephansky, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Blood|December 1, 2018
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomasRaphael Koch, Amanda L Christie, Jennifer L Crombie, et al.
Nature Biotechnology|September 7, 2016
High-throughput measurement of single-cell growth rates using serial microfluidic mass sensor arraysNathan Cermak, Selim Olcum, Francisco Feijó Delgado, et al.
Disaster Medicine and Public Health Preparedness|March 16, 2011
Allocation of scarce resources after a nuclear detonation: setting the contextAnn R Knebel, C Norman Coleman, Kenneth D Cliffer, et al.
Health Physics|January 1, 2015
Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterpriseC Norman Coleman, Julie M Sullivan, Judith L Bader, et al.
Blood|October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphomaCaron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Molecular Cancer Therapeutics|August 29, 2023
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1Adrian Schwarzer, Matheus Oliveira, Marc-Jens Kleppa, et al.
Blood|October 7, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemiaMarlise R Luskin, Mark A Murakami, Julia Keating, et al.
Leukemia|July 31, 2025
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphomaTayla B Heavican-Foral, Felix Korell, Irene Scarfò, et al.
Cell|March 20, 2018
B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell MalignanciesGang Xiao, Lai N Chan, Lars Klemm, et al.
The Journal of Clinical Investigation|August 23, 2019
DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistanceKatsuhiro Togami, Timothy Pastika, Jason Stephansky, et al.
Pageof 18